Ambirix
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ambirix, covering 2024-02-08 to 2026-08-03. Get the full timeline:
Most recent: EMA Authorised: Ambirix (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.